Tremmel, Daniel M.
Sackett, Sara Dutton
Feeney, Austin K.
Mitchell, Samantha A.
Schaid, Michael D.
Polyak, Erzsebet
Chlebeck, Peter J.
Gupta, Sakar
Kimple, Michelle E.
Fernandez, Luis A.
Odorico, Jon S.
Funding for this research was provided by:
National Institutes of Health (1F31DK125021-01, R21AI126419, 2UC4DK098085, R01 DK102598)
Juvenile Diabetes Research Foundation International (1-SRA-2016-168-S-B)
National Center for Advancing Translational Sciences (UL1TR002373)
U.S. Department of Veterans Affairs (I01 BX003700)
Article History
Received: 30 November 2021
Accepted: 4 April 2022
First Online: 3 May 2022
Competing interests
: The authors declare the following competing financial interest(s): JSO is scientific co-founder of Regenerative Medical Solutions, Inc. and has stock equity.